Recursion (RXRX) lost more than 4% in the early premarket trading on Thursday after a $200M equity offering from the AI-driven drug discovery firm overshadowed a decision by Sanofi (SNY) to select its ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Leading Healthcare Investors, including Janus Henderson Investors, Invus, Longaeva Partners, ARK Invest, Driehaus Capital Management and other prominent healthcare specialists and mutual funds invest ...

SPOILER ALERT: This article contains spoilers for the first season of “Below,” now streaming on Netflix. Netflix’s new mystery series “Below” has arrived, and audiences are being transported to the ...

Ted Lasso‘s Season 4 finale promised “Big changes in bunches,” and boy did it deliver. After a three-year hiatus, Apple TV’s Emmy-winning comedy made its highly anticipated return and saw Ted (Jason ...

Cathie Wood’s ARK Invest sold 90,713 shares of Twist Bioscience worth about $17.1 million on October 5, 2026. ARK bought 1,482,357 shares of Recursion Pharmaceuticals worth about $6.1 million. ARK ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

Spoiler alert! We're discussing major details about the ending of “Verity” (in theaters now), adapted from Colleen Hoover’s 2018 novel. Stop reading now if you haven’t seen it yet and don’t want to ...

What is the plot of Verity? Instead of a nanny, Lowen Ashleigh (Johnson) is a up-and-coming writer hired to help famed author Verity Crawford (Hathaway) finish her series of twisted psychological ...

If you’ve read Colleen Hoover’s “Verity,” consider yourself primed for the movie adaptation of the psychological thriller. Released in 2018, Hoover’s dark love triangle shot to the top of the ...